Pages that link to "Q48260745"
Jump to navigation
Jump to search
The following pages link to In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors (Q48260745):
Displaying 7 items.
- WAY-100635 is a potent dopamine D4 receptor agonist (Q28258364) (← links)
- Participation of 5-HT(1B) receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice: pharmacological analysis in 5-HT(1B) receptor knockout mice (Q35044526) (← links)
- Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease (Q48292693) (← links)
- Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output (Q48371859) (← links)
- R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex (Q74105988) (← links)
- Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development (Q74233834) (← links)
- Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease (Q83257922) (← links)